FLGT Fulgent Genetics, Inc.

NAS · US · Healthcare · Diagnostics & Research · fulgentgenetics.com

20.57USD-0.05%Mkt Cap: 565.99M $P/E: —1d ago

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

IDEXX Laboratories, Inc.

$39.97BUSDP/E 35.6

MTD

Mettler-Toledo International Inc.

$30.73BUSDP/E 34.6

Labcorp Holdings Inc.

$25.30BUSDP/E 25.8

DGX

Quest Diagnostics Incorporated

$25.06BUSDP/E 24.1

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.87BUSDP/E 35.5

ERF

Eurofins Scientific SE

$14.23BUSDP/E 26.6

CRL

Charles River Laboratories International, Inc.

$14.34BUSD

ICLR

ICON Public Limited Company

Key Statistics

Company

Market Cap565.99M USD

Enterprise Value313.20M USD

Revenue (TTM)323.93M USD

Gross Profit130.88M USD

Net Income (TTM)-60.51M USD

Revenue/Share10.74 USD

Last Price20.57 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-14.91

PEG—

EV/EBITDA-3.50

EV/Revenue0.97

P/S1.75

P/B0.57

EPS (TTM)-2.82

EPS (Forward)-1.38

52W Range

13.4640% of range31.04

52W High31.04 USD

52W Low13.46 USD

Profitability

Gross Margin40.56%

Oper. Margin-39.35%

EBITDA Margin-27.62%

Profit Margin-18.75%

ROE-5.44%

ROA-4.99%

Growth

Revenue Growth4.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-101.64M USD

CapEx (TTM)22.57M USD

FCF Margin-28.06%

FCF Yield-16.06%

Net Debt-247.43M USD

Net Debt/EBITDA2.77

Balance Sheet

Debt/Equity0.01

Current Ratio6.34

Quick Ratio4.57

Book Value/Sh36.40 USD

Cash/Share9.34 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)19.00 USD

Upside (mean)-7.6%

Target Range19.00 USD – 19.00 USD

# Analysts1

Ownership

Shares Out.27.52M

Float16.69M

Insiders37.75%

Institutions58.40%

Short Interest

Short Ratio8.0d

Short % Float13.53%

Short % Out.8.42%

Shares Short2.32M

Short (prev mo.)2.56M

Technical

SMA 5020.07 (+2.5%)

SMA 20019.98 (+2.9%)

Beta0.93

S&P 52W Chg16.45%

Avg Vol (30d)306.02K

Avg Vol (10d)275.99K

Technical Indicators

RSI (14)47.0

MACD0.3790

MACD Signal0.5388

MACD Hist.-0.1598

BB Upper22.83 USD

BB Middle21.26 USD

BB Lower19.70 USD

BB Width14.75%

ATR (14)0.8365 USD

Vol Ratio (20d)0.91x